CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene deletion mutation form of cystic fibrosis patients and application of CFTR gene deletion mutation form
A cystic fibrosis, residue technology, applied in the fields of application, genetic engineering, plant gene improvement, etc., can solve the problem of no incidence of the disease, and achieve the effect of great application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0038] 1. Information about the patient
[0039] Basic situation of the child: A 1-year-old female was admitted to the hospital in August 2015 due to "repeated coughing and wheezing for more than 3 months".
[0040] The course of the child's disease: 3 months before admission, the child developed a cough after contact with a "cold" patient. It was a paroxysmal continuous cough, which was obvious in the morning, with phlegm in the throat, accompanied by wheezing, and improved after nebulization treatment in the local hospital; admission In the first two months, due to aggravated cough and wheezing, he went to the local hospital again and was diagnosed with "severe pneumonia". stunted,
[0041]Parents and family conditions of the child: the father is British and has a history of asthma; he denies a family history of cystic fibrosis.
[0042] The results of physical examination in August 2015: body temperature 36.9 ℃, weight 7.5kg, body length 67cm, head circumference 44cm, res...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com